Read EMJ Innovations' congress review of last year's GIANT Health event in anticipation
Posted:
In the build-up to GIANT Health Event 2022 #GIANT2022, refresh your knowledge of last year's congress, featured in EMJ Innovations' 6.1 journal. Read more here.
Antimicrobial resistance could claim almost two million lives a year by 2050. Now, researchers believe they could use #AI to predict which bugs will become resistant so that we can better prepare.
Read the full article here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…